2GAF image
Deposition Date 2006-03-08
Release Date 2006-05-16
Last Version Date 2024-10-09
Entry Detail
PDB ID:
2GAF
Keywords:
Title:
Crystal Structure of the Vaccinia Polyadenylate Polymerase Heterodimer (apo form)
Biological Source:
Source Organism:
Vaccinia virus (Taxon ID: 10245)
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.28
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase
Mutations:R140A, K142A, R143A
Chain IDs:A
Chain Length:297
Number of Molecules:1
Biological Source:Vaccinia virus
Polymer Type:polypeptide(L)
Molecule:Poly(A) polymerase catalytic subunit
Gene (Uniprot):OPG063
Mutations:L36S
Chain IDs:B (auth: D)
Chain Length:469
Number of Molecules:1
Biological Source:Vaccinia virus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MSE A MET SELENOMETHIONINE
Primary Citation
Crystal structures of the vaccinia virus polyadenylate polymerase heterodimer: insights into ATP selectivity and processivity.
Mol.Cell 22 339 349 (2006)
PMID: 16678106 DOI: 10.1016/j.molcel.2006.03.015

Abstact

Polyadenylation of mRNAs in poxviruses, crucial for virion maturation, is carried out by a poly(A) polymerase heterodimer composed of a catalytic component, VP55, and a processivity factor, VP39. The ATP-gamma-S bound and unbound crystal structures of the vaccinia polymerase reveal an unusual architecture for VP55 that comprises of N-terminal, central or catalytic, and C-terminal domains with different topologies and that differs from many polymerases, including the eukaryotic poly(A) polymerases. Residues in the active site of VP55, located between the catalytic and C-terminal domains, make specific interactions with the adenine of the ATP analog, establishing the molecular basis of ATP recognition. VP55's concave surface docks the globular VP39. A model for RNA primer binding that involves all three VP55 domains and VP39 is proposed. The model supports biochemical evidence that VP39 functions as a processivity factor by partially enclosing the RNA primer at the heterodimer interface.

Legend

Protein

Chemical

Disease

Primary Citation of related structures